Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bicoll specializes in the discovery and optimization of novel small molecules from natural sources using proprietary technology platforms. The company has a proven track record with peer-reviewed publications and patents. Its main focus areas are neurodegenerative disorders and longevity. It provides preclinical candidates for these indications while also supporting external partners’ drug discovery pipelines through its advanced medicinal chemistry services. Some products derived from its research have reached the market via partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bicoll GmbH.